Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lexicon Pharmaceutcl (NQ: LXRX )

1.528 -0.032 (-2.08%)
Streaming Delayed Price Updated: 11:56 AM EDT, Apr 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Lexicon Pharmaceutcl

< Previous 1 2 3 4 5 Next >
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers EyePoint Pharmaceuticals (NASDAQ:EYPT) stock increased by 44.96% to $20.31 during Monday's pre-market session. The market value of their outstanding shares is... 
Via Benzinga
81 Biggest Movers From Yesterday
Gainers Evaxion Biotech A/S (NASDAQ: EVAX) shares jumped 95.1% to close at $12.68 on Thursday after dropping over 10% on Wednesday. TDH Holdings, Inc. (NASDAQ: PETZ) jumped 79.8... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Evaxion Biotech (NASDAQ:EVAX) shares increased by 244.61% to $22.4 during Thursday's pre-market session. The company's market cap stands at $430.0 million... 
Via Benzinga
Recap: Lexicon Pharmaceuticals Q3 Earnings
Lexicon Pharmaceuticals (NASDAQ:LXRX) reported its Q3 earnings results on Wednesday, November 3, 2021 at 04:00 PM. Here's what investors need to know about the announcement.... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Voyager Therapeutics (NASDAQ:VYGR) shares increased by 46.15% to $3.61 during Wednesday's pre-market session. The company's market cap stands at $136.9... 
Via Benzinga
Why Cramer Likes Bank of America, Ethereum And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said he likes Bank of America Corp (NYSE: BAC). He met the CFO over the weekend and Cramer thinks it's a... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Valneva (NASDAQ:VALN) stock rose 17.45% to $45.22 during Monday's pre-market session. The market value of their outstanding shares is at $2.2 billion.... 
Via Benzinga
60 Biggest Movers From Friday
Gainers Vinco Ventures, Inc. (NASDAQ: BBIG) shares rose 80.9% to close at $5.30 on Friday. The company recently reported a Q2 loss of $5.13 per share. Navios Maritime Acquisition... 
Via Benzinga
Lexicon Touts Analyses From Two Phase 3 Trials Of Its Heart Failure Drug
Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) has presented additional analyses from SOLOIST and SCORED Phase 3 trials evaluating heart failure candidate... 
Via Benzinga
Overview Of Value Stocks In The Healthcare Sector
Understanding Value Stocks A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be... 
Via Benzinga
The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
Exposures Product Safety
Lexicon Pharmaceuticals: Q2 Earnings Insights
Shares of Lexicon Pharmaceuticals (NASDAQ:LXRX) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share were up 80.00% over the past year... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Moderna (NASDAQ:MRNA) stock increased by 7.67% to $279.6 during Friday's pre-market session. The company's market cap stands at $112.2 billion. Eton... 
Via Benzinga
55 Biggest Movers From Friday
Gainers IKONICS Corporation (NASDAQ: IKNX) shares surged 64.3% to close at $18.56 on Friday after the company reported a merger deal with TeraWulf. Alpha Teknova, Inc. (NASDAQ:... 
Via Benzinga
Earnings Scheduled For July 30, 2021
Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its second quarter. • Embraer (NYSE:ERJ) is... 
Via Benzinga
Recap: Lexicon Pharmaceuticals Q1 Earnings
Shares of Lexicon Pharmaceuticals (NASDAQ:LXRX) increased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 76.19% over the... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.